Ischemic and Bleeding Outcomes After Angiolite Stent Implantation and an Abbreviated Dual Antiplatelet Therapy
A phase 3 trial registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 2312 participants.
Also called NCT05952206
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 2,312 participants
- Sponsor
- Registry
-
NCT05952206
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Belgium, France, Spain
- Registry status
- Active, not recruiting
Technical summary
Registry record NCT05952206. Randomized; no masking; primary purpose treatment. Start 2023-10-13 (actual); primary completion 2027-01-13 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Ischemic and Bleeding Outcomes After Angiolite Stent Implantation and an Abbreviated Dual Antiplatelet Therapy
- Acronym
- ANGIODAPT
- Condition
- Coronary Artery Disease
- Intervention (Device)
- Angiolite: Sirolimus-eluting stent
- Intervention (Device)
- Xience: Everolimus-eluting stent
- Intervention (Drug)
- 1-month DAPT
- Intervention (Drug)
- 12-month DAPT (Standard of care)
- Lead sponsor
- iVascular S.L.U.
Record details
- Record id
cardio:ct-nct05952206- Content hash
27020387db6a95904d680e70b22988a581582cafbe2c3a72bb6de9a0e7892081